Health technology assessment and price negotiation alignment for rare disorder drugs in Canada: Who benefits?

Overview of attention for article published in Orphanet Journal of Rare Diseases, June 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 1 X post from an account with 1,415 followers.

Health technology assessment and price negotiation alignment for rare disorder drugs in Canada: Who benefits? https://t.co/SlCO0H9L5i

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.